Cancer Family
Neck Neoplasm
CI-CAN-00000283Explore in graph →
Non-malignant634 active trials11 approved drugs67 evidence items
- NCIt
- C3260
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000283Explore in graph →
Clinical trials
2,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03488134 | Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3 | completed | — | 74 | National Taiwan University HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT03558191 | SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy. | completed | Phase 2 | 156 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Mar 15, 2024 |
| clinicaltrials |
| NCT02703493 | Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal Cancer | completed | N/A | 39 | Northwell HealthOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06161233 | Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy(CAPABLE-IT) | completed | N/A | 56 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT02592356 | Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer | completed | N/A | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT06283368 | Red Blood Cell Distributions (RDW, RDW-CW) and Lymphocyte Monocyte Ratios (LMR) for the Malignant Thyroid Nodules | completed | — | 172 | Kahramanmaras Sutcu Imam UniversityOTHER | 0 | Mar 1, 2024 | clinicaltrials |
| NCT03653039 | Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy(Tritube) | completed | N/A | 48 | Michael Seltz KristensenOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT03012620 | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types(AcSé) | completed | Phase 2 | 334 | UNICANCEROTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT03788499 | Using Massage of Maxillofacial and Oral Cavity to Prevent Radioactive Oral Mucositis | completed | N/A | 160 | Xinqiao Hospital of ChongqingOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT03791944 | 3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma | completed | N/A | 100 | Xinqiao Hospital of ChongqingOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06275425 | Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia | completed | N/A | 106 | Yonsei UniversityOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT06256263 | Stapler Versus Conventional Pharyngeal Repair After Total Larygectomy | completed | N/A | 58 | Mansoura UniversityOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT00390325 | Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Feb 6, 2024 | clinicaltrials |
| NCT05564286 | Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer | completed | Phase 3 | 116 | Shantou University Medical CollegeOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06243965 | Is Desmoplastic Stromal Reaction Useful to Modulate Lymph Node Dissection in Sporadic Medullary Thyroid Carcinoma?(DSR-MTC) | completed | — | 246 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT06244394 | Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma | completed | — | 230 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | completed | Phase 1 / Phase 2 | 46 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT00342446 | A Follow-up Study of Women Evaluated and Treated for Infertility | completed | — | 12,193 | National Cancer Institute (NCI)NIH | 1 | Jan 11, 2024 | clinicaltrials |
| NCT02757222 | Dose Escalation Versus Standard in Laryngopharyngeal Cancers(INTELHOPE) | completed | N/A | 100 | Tata Medical CenterOTHER | 1 | Dec 28, 2023 | clinicaltrials |
| NCT01709435 | Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 2 | Dec 22, 2023 | clinicaltrials |
| NCT06124469 | UNN-RADS Scale for Diagnosing Lymph Node Metastasis in Patients With History of Thyroid Cancer | completed | — | 99 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 9, 2023 | clinicaltrials |
| NCT03906058 | Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy | completed | Phase 2 | 39 | Sun Yat-sen UniversityOTHER | 1 | Oct 25, 2023 | clinicaltrials |
| NCT01332682 | Resistance Training and Physical Functioning in Head and Neck Cancer Patients | completed | Phase 1 | 18 | University of Alabama at BirminghamOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT00719615 | Assess Vitamin D Levels in Those With & Without Thyroid Cancer | completed | — | 111 | University of NebraskaOTHER | 1 | Oct 16, 2023 | clinicaltrials |
| NCT05368025 | Staying Connected: a Mobile Health Study With the Noona® and Mobili-T® Systems | completed | — | 65 | University of AlbertaOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06067594 | Calcitonin in Needle Wash Using Electrochemiluminescence Method For Diagnosis Of Medullary Thyroid Carcinoma. | completed | — | 155 | Austral University, ArgentinaOTHER | 1 | Oct 6, 2023 | clinicaltrials |
| NCT06068101 | Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer | completed | — | 274 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Oct 5, 2023 | clinicaltrials |
| NCT05217147 | An Investigation of Biomarker Candidate Molecules in Laryngeal Carcinoma | completed | — | 80 | Hacettepe UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT01659385 | Leptin Levels in Papillary Thyroid Cancer(LL-PTC) | completed | — | 18 | University of NebraskaOTHER | 1 | Sep 6, 2023 | clinicaltrials |
| NCT02347683 | Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy | completed | — | 50 | University of NebraskaOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT00568438 | Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample | completed | — | 169 | Stanford UniversityOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT03598218 | Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma | completed | N/A | 30 | Wei JiangOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT03602079 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | completed | Phase 1 / Phase 2 | 49 | Klus Pharma Inc.INDUSTRY | 1 | Aug 3, 2023 | clinicaltrials |
| NCT02988817 | Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 306 | GenmabINDUSTRY | 6 | Aug 1, 2023 | clinicaltrials |
| NCT04929080 | The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC | completed | Phase 1 / Phase 2 | 149 | Shanghai Junshi Bioscience Co., Ltd.OTHER | 1 | Aug 1, 2023 | clinicaltrials |
| NCT03300284 | Decision Making and Psychological Outcomes in Low-Risk Papillary Thyroid Cancer | completed | — | 186 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT01633541 | Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer | completed | Phase 2 | 55 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 20, 2023 | clinicaltrials |
| NCT02947035 | Molecular Testing to Direct Extent of Initial Thyroid Surgery | completed | Phase 2 | 100 | University of PittsburghOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT02611960 | Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122) | completed | Phase 3 | 233 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jul 13, 2023 | clinicaltrials |
| NCT04572100 | Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer | completed | Phase 1 | 50 | University of ChicagoOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT00834093 | A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | completed | Phase 2 | 18 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT02578641 | A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients(VANCE) | completed | Phase 3 | 330 | Tessa TherapeuticsINDUSTRY | 5 | Jun 28, 2023 | clinicaltrials |
| NCT01321554 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)(SELECT) | completed | Phase 3 | 392 | Eisai Inc.INDUSTRY | 23 | Jun 22, 2023 | clinicaltrials |
| NCT01935921 | Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer | completed | Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Jun 15, 2023 | clinicaltrials |
| NCT02303444 | An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors(RIFTOS MKI) | completed | — | 667 | BayerINDUSTRY | 19 | Jun 8, 2023 | clinicaltrials |
| NCT01711541 | Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer | completed | Phase 1 / Phase 2 | 24 | National Cancer Institute (NCI)NIH | 1 | Jun 7, 2023 | clinicaltrials |
| NCT03418792 | Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx | completed | N/A | 40 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05873283 | Papillary Thyroid Cancer and Central Lymp Node Dissection | completed | — | 250 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | May 24, 2023 | clinicaltrials |
| NCT03429868 | PET and MRI in Prognosis Prediction of NPC | completed | N/A | 180 | Chang Gung Memorial HospitalOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT05698667 | Outpatient Ultrasound for the Diagnostic Work-up of Oropharynx Cancer | completed | N/A | 26 | Rigshospitalet, DenmarkOTHER | 1 | May 6, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 19, 2024source: clinicaltrials